Prolonged infusion time of cyclophosphamide plus granulocyte colony-stimulating factor (G-CSF) as a mobilization regimen may improve mobilization efficiency in newly diagnosed multiple myeloma patients: a single center experience.

Yanjuan LiJunru LiuBeihui HuangMeilan ChenJingli GuJuan Li

Published in: Annals of medicine (2023)

For patients with NDMM, 24-h continuous infusion of CTX plus G-CSF contributes to improved mobilization efficiency and equivalent toxicity as a stem cell mobilization regimen.

Keyphrases

newly diagnosed
stem cells
low dose
end stage renal disease
multiple myeloma
chronic kidney disease
oxidative stress
prognostic factors
peripheral blood
patient reported outcomes
escherichia coli
cell therapy